Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis

Conditions: Decompensated Cirrhosis Interventions: Dietary Supplement: Isomaltooligosaccharides (IMO) Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials